(Q83993895)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

Optic neuritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

D Pau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

N Al Zubidi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

S Yalamanchili

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

G T Plant

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

A G Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

29 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

833-842

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial

30 January 2020

cites work

1 reference

12 December 2020

Inflammation and degeneration in multiple sclerosis

1 reference

12 December 2020

Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.

1 reference

12 December 2020

Plasma exchange for severe optic neuritis: treatment of 10 patients

1 reference

12 December 2020

Optic neuritis in adults and children

1 reference

12 December 2020

Etiological profile of presumptive optic neuritis in China.

1 reference

12 December 2020

A systematic review of the epidemiology of multiple sclerosis in South America

1 reference

12 December 2020

Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese

1 reference

12 December 2020

Environmental changes and epidemiology of multiple sclerosis in the French West Indies.

1 reference

12 December 2020

Optic neuritis: a review

1 reference

12 December 2020

Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis

1 reference

12 December 2020

Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study

1 reference

12 December 2020

Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients

1 reference

12 December 2020

Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.

1 reference

12 December 2020

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up

1 reference

12 December 2020

Optic neuritis in Singapore.

1 reference

12 December 2020

Optic neuritis incidence is increased in spring months in patients with asymptomatic demyelinating lesions.

1 reference

12 December 2020

Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years

1 reference

12 December 2020

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study

1 reference

12 December 2020

MRI only conversion to multiple sclerosis following a clinically isolated syndrome.

1 reference

12 December 2020

The human microbiome in multiple sclerosis: pathogenic or protective constituents?

1 reference

12 December 2020

Optic neuritis and multiple sclerosis. An epidemiologic study

1 reference

12 December 2020

Multiple sclerosis among immigrants

1 reference

12 December 2020

Relative Afferent Pupillary Defects in Optic Neuritis

1 reference

12 December 2020

Optic neuritis or multiple sclerosis

1 reference

12 December 2020

Optic neuritis: a prospective study

1 reference

12 December 2020

Multiple sclerosis in a black Cameroonian woman.

1 reference

12 December 2020

Pathogenesis of multiple sclerosis--the immune diathesis and the role of viruses.

1 reference

12 December 2020

Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial

1 reference

12 December 2020

Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group

1 reference

12 December 2020

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

1 reference

12 December 2020

Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognising multiple myelin proteins are accumulated in cerebrospinal fluid

1 reference

12 December 2020

Optic neuritis: A population-based study in Olrnsted County, Minnesota

1 reference

12 December 2020

Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial

1 reference

12 December 2020

Color vision defect type and spatial vision in the optic neuritis treatment trial.

1 reference

12 December 2020

Does optic disc appearance distinguish ischemic optic neuropathy from optic neuritis?

1 reference

12 December 2020

The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial

1 reference

12 December 2020

Risk factors for developing multiple sclerosis after childhood optic neuritis

1 reference

12 December 2020

Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group

1 reference

12 December 2020

Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Optic neuritis in African Americans

1 reference

12 December 2020

A bedside test to determine motion stereopsis using the Pulfrich phenomenon

1 reference

12 December 2020

The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis. Optic Neuritis Study Group

1 reference

12 December 2020

Perils and pitfalls in the interpretation of clinical trials: a reflection on the recent experience in multiple sclerosis

1 reference

12 December 2020

Optic neuritis in children: clinical features and visual outcome

1 reference

12 December 2020

A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis.

1 reference

12 December 2020

Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)

1 reference

12 December 2020

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

12 December 2020

EXERCISE AND THE OPTIC NEUROPATHY OF MULTIPLE SCLEROSIS

1 reference

12 December 2020

A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis

1 reference

12 December 2020

Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?

1 reference

12 December 2020

Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis

1 reference

12 December 2020

Role of return migration in the emergence of multiple sclerosis in the French West Indies

1 reference

12 December 2020

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

12 December 2020

Clinical practice. Optic neuritis

1 reference

12 December 2020

Revised diagnostic criteria for neuromyelitis optica

1 reference

12 December 2020

Quantifying axonal loss after optic neuritis with optical coherence tomography.

1 reference

12 December 2020

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

1 reference

12 December 2020

Multiple sclerosis in Jordan: a clinical and epidemiological study

1 reference

12 December 2020

Optic neuritis and the neuro-ophthalmology of multiple sclerosis

1 reference

12 December 2020

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

1 reference

12 December 2020

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

12 December 2020

Physiology, assessment, and disorders of the pupil

1 reference

12 December 2020

Optic neuritis in children

1 reference

12 December 2020

Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis.

1 reference

12 December 2020

Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases

1 reference

12 December 2020

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

12 December 2020

A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis

1 reference

12 December 2020

The controlled high risk Avonex multiple sclerosis trial (CHAMPS Study).

1 reference

12 December 2020

Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance

1 reference

12 December 2020

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

12 December 2020

Management of acute optic neuritis

1 reference

12 December 2020

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

1 reference

12 December 2020

Neuromyelitis optica: clinical predictors of a relapsing course and survival

1 reference

12 December 2020

Identifiers

DOI

10.1038/EYE.2011.81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527960%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

21527960

1 reference